Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.16B |
| 2 |
Eli Lilly
LLY
|
+$1.9B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.09B |
| 4 |
Cigna
CI
|
+$883M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.49B |
| 2 |
Comcast
CMCSA
|
+$1.34B |
| 3 |
Stryker
SYK
|
+$1.31B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 5 |
Walt Disney
DIS
|
+$1.2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Communication Services | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Fidelity Momentum Factor ETF
FDMO
$922M
| $5.68M | ﹤0.01% |
187,401
+175,041
| +1,416% | +$6.21M |
|
1802
Barclays
BCS
$93.7B
| $5.65M | ﹤0.01% |
1,247,642
+1,014,426
| +435% | +$7.83M |
|
1803
UroGen Pharma
URGN
$2.3B
| $5.61M | ﹤0.01% |
314,603
| – | – |
|
|
DENN
1804
DELISTED
Denny's
DENN
| $5.58M | ﹤0.01% |
726,984
-527,466
| -42% | -$8.95M |
|
1805
Arcosa
ACA
$7.12B
| $5.54M | ﹤0.01% |
139,383
-266,750
| -66% | -$11.3M |
|
1806
Vishay Intertechnology
VSH
$5.11B
| $5.53M | ﹤0.01% |
383,392
-15,412
| -4% | -$291K |
|
1807
NextCure
NXTC
$30.8M
| $5.5M | ﹤0.01% |
12,374
| – | – |
|
1808
Fidelity MSCI Information Technology Index ETF
FTEC
$21.1B
| $5.5M | ﹤0.01% |
87,663
-6,065
| -6% | -$435K |
|
1809
Compass Minerals
CMP
$1.13B
| $5.48M | ﹤0.01% |
142,432
+26,121
| +22% | +$1.42M |
|
|
ELAT
1810
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $5.47M | ﹤0.01% |
+122,900
| New | +$5.89M |
|
|
JNPR
1811
DELISTED
Juniper Networks
JNPR
| $5.47M | ﹤0.01% |
286,049
-7,577
| -3% | -$170K |
|
1812
Equitable Holdings
EQH
$14B
| $5.47M | ﹤0.01% |
378,498
-5,133,591
| -93% | -$112M |
|
|
SY
1813
So-Young International
SY
$222M
| $5.46M | ﹤0.01% |
+533,200
| New | +$6.5M |
|
1814
Colliers International
CIGI
$5.3B
| $5.46M | ﹤0.01% |
+114,094
| New | +$8.56M |
|
1815
Belden
BDC
$5.26B
| $5.46M | ﹤0.01% |
151,201
+1
| +0% | +$46 |
|
|
CLR
1816
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $5.44M | ﹤0.01% |
712,028
-360,474
| -34% | -$8.04M |
|
1817
Arcturus Therapeutics
ARCT
$214M
| $5.44M | ﹤0.01% |
400,000
| – | – |
|
|
STKL
1818
DELISTED
SunOpta
STKL
| $5.43M | ﹤0.01% |
3,152,251
-26,009
| -0.8% | -$64.9K |
|
1819
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
| $5.4M | ﹤0.01% |
201,625
-130
| -0.1% | -$4.61K |
|
|
MCF
1820
DELISTED
Contango Oil & Gas Co.
MCF
| $5.37M | ﹤0.01% |
3,580,169
-1,994,470
| -36% | -$6.26M |
|
|
IMGN
1821
DELISTED
Immunogen Inc
IMGN
| $5.37M | ﹤0.01% |
1,573,748
+820,549
| +109% | +$3.59M |
|
1822
Interface
TILE
$2.24B
| $5.36M | ﹤0.01% |
709,400
-60,600
| -8% | -$846K |
|
1823
Canadian Imperial Bank of Commerce
CM
$109B
| $5.35M | ﹤0.01% |
183,486
+143,476
| +359% | +$5.34M |
|
|
SGMO
1824
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $5.28M | ﹤0.01% |
828,127
-1,193,200
| -59% | -$8.85M |
|
|
NFH
1825
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
| $5.27M | ﹤0.01% |
+638,900
| New | +$5.81M |
|
Similar funds
Fidelity Investments's Q1 2020 Portfolio in Review
As of Q1 2020, Fidelity Investments held 4,600 positions worth $722B, down 20% from $906B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fidelity Investments's Q1 2020 filing shows 372 new, 1,381 increased, 1,824 reduced and 431 closed positions. Its largest new stake was 1Life Healthcare: 9,509,562 shares worth $164M. The largest sale was Amgen, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q1 2020 buy was 1Life Healthcare: 9,509,562 shares worth $164M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q1 2020, an estimated $2.16B increase.
- Fidelity Investments's biggest Q1 2020 reduction was Amgen, cutting an estimated $1.49B.
- Fidelity Investments fully exited Taubman Centers Inc. in Q1 2020, selling an estimated $106M.
- Fidelity Investments's ten largest holdings make up 27% of its $722B portfolio in Q1 2020.
- Fidelity Investments opened 372 new positions and closed 431 in Q1 2020.
- Fidelity Investments's portfolio value fell 20% quarter-over-quarter to $722B.
Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.